Pfizer fourth quarter net rises 4.74% to Rs 109 cr, revenue from operations at Rs 536 cr; shares up
5 years, 7 months ago

Pfizer fourth quarter net rises 4.74% to Rs 109 cr, revenue from operations at Rs 536 cr; shares up

Firstpost  

Pfizer said its board has recommended a dividend of Rs 22.50 per equity share of Rs 10 each for the year ended 31 March, 2019. New Delhi: Pharma firm Pfizer on Tuesday reported a 4.74 percent rise in net profit to Rs 109.47 crore for the quarter ended 31 March, 2019. The company had posted a net profit of Rs 104.51 crore in the corresponding period of the previous fiscal, Pfizer said in a filing to the BSE. The company said its board has recommended a dividend of Rs 22.50 per equity share of Rs 10 each for the year ended 31 March, 2019.

Crore Pfizer Net Profit  31  quarter  cr  crore  operations  fourth  previous  shares  revenue  rises  stood  share  profit  rs  net  pfizer  ended

History of this topic

Pfizer reports $11.4 billion profit in Dutch operations despite post-pandemic decline
3 weeks, 6 days ago

Pfizer reports $11.4 billion profit in Dutch operations despite post-pandemic decline

NL Times  

Pharmaceutical giant Pfizer has recorded 11.4 billion dollars in profit from its Dutch subsidiary, C.P. Pfizer’s global revenue fell sharply from 74.4 billion dollars in 2022 to 46.9 billion euros over the past year. Pfizer's Dutch arm, which had reported 19.9 billion dollars in profits in 2021/2022 and 18.7 billion dollars in 2020/2021, has now returned to pre-pandemic profit levels …

PFC share price jumps 9% post Q2 results; brokerages see 16-28% potential upside in this PSU stock
1 month, 4 weeks ago

PFC share price jumps 9% post Q2 results; brokerages see 16-28% potential upside in this PSU stock

Live Mint  

PFC share price: Power Finance Corporation share price surged nearly 9% in Monday's session after the company reported a nearly 9% increase in consolidated net profit to ₹7,214.90 crore for the September quarter, primarily driven by greater revenues. For the period from April to September FY25, the company experienced a 14% increase in consolidated profit after tax to ₹14,397 crore …

Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast
11 months, 1 week ago

Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast

Associated Press  

Pfizer turned in a better-than-expected fourth quarter, boosted by products outside the drugmaker’s slumping COVID-19 vaccine and treatment. The New York drugmaker also said Tuesday it’s reaffirming its forecast for 2024, a month after surprising Wall Street with an initial outlook that missed consensus. In the fourth quarter, Pfizer said it booked 8% operational revenue growth outside its market-leading COVID …

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products
1 year, 2 months ago

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Shares of Pfizer are in …

PFC Q1 Results: Net profit rises 31% on year to ₹5,982.14 crore
1 year, 4 months ago

PFC Q1 Results: Net profit rises 31% on year to ₹5,982.14 crore

Live Mint  

Power Finance Corporation Ltd on Friday reported an 30.6% year-on-year rise in its consolidated net profit for the fiscal's first quarter ended June to ₹5,982.14 crore. The company's total consolidated revenue from operations rose 13.3% on year to ₹20,992.49 crores during the quarter ended June from ₹18,532.25 crore in Q1FY23. According to the company's filing, on consolidated basis operating margin …

Pfizer Q1 Results: Net profit jumps multi-fold to ₹93.5 crore
1 year, 4 months ago

Pfizer Q1 Results: Net profit jumps multi-fold to ₹93.5 crore

Live Mint  

Pfizer Limited released its Q1 results on Friday and posted a multi-fold year-on-year jump in its net profit which touched ₹93.5 crore during the quarter ending June 2023. Sequentially, the company's net profit plunged 27% quarter-on-quarter as it stood at ₹129.6 crore during the quarter ending March 2023. Recall of some products Pfizer said that during the April -June quarter, …

Stocks to Watch: HDFC, Pfizer, Adani Group, PVR Inox, P&G Health, Vedanta
1 year, 7 months ago

Stocks to Watch: HDFC, Pfizer, Adani Group, PVR Inox, P&G Health, Vedanta

Live Mint  

Here are the top 10 stocks that could be in focus in today's trade: HDFC: Mortgage lender Housing Development Finance Corporation would issue bonds through a private placement to raise up to ₹8,000 crore and strengthen its financial position. Pfizer: For the March quarter, Pfizer Ltd's standalone net profit rose 3.1% to ₹129.65 crore from ₹125.79 crore during the same …

Pfizer Q4FY23 Results: Net profit up 3.1%, declares dividend
1 year, 7 months ago

Pfizer Q4FY23 Results: Net profit up 3.1%, declares dividend

Live Mint  

For the the quarter ended March, Pfizer Ltd's standalone net profit rose 3.1% on year to ₹129.65 crore from ₹125.79 crore during the same period last year. The company has declared final dividend of ₹35 per share and special dividend of ₹5 per share for the FY23. “The board of directors has at its meeting held today has recommended a …

Pfizer tops Q1 forecasts; vaccine sales slide as expected
1 year, 8 months ago

Pfizer tops Q1 forecasts; vaccine sales slide as expected

Associated Press  

Pfizer beat first-quarter forecasts as revenue took an expected dip, but the drugmaker predicted a sales rally later this year. The company said Tuesday that it also expects significantly lower sales from its vaccine and COVID-19 treatment, Paxlovid, in the second quarter compared to the first. Plus Pfizer also expects a revenue boost later this year from new product launches …

Pfizer tops Q3 earnings views, makes progress on COVID shot
4 years, 2 months ago

Pfizer tops Q3 earnings views, makes progress on COVID shot

Live Mint  

Drugmaker Pfizer saw its third-quarter profit plunge 71%, mainly due to an $8.1 billion gain a year earlier from selling its consumer health care business to a GlaxoSmithKline joint venture, but managed to top Wall Street expectations. Pfizer already has contracts with the United States, the European Union and about 10 countries to supply hundreds of millions of doses of …

Discover Related